ReviewNature reviews. Cancer2016
Engineered T cells: the promise and challenges of cancer immunotherapy.
Andrew D Fesnak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
594 papers cite itlatest 60 shown
this paperpooled itcites it